Ascendis Pharma A/S
F:A71
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Ascendis Pharma A/S
F:A71
|
DK |
|
Tamburi Investment Partners SpA
MIL:TIP
|
IT |
|
B
|
Bank of Communications Co Ltd
XMUN:C4C
|
CN |
|
K
|
KGHM Polska Miedz SA
F:KGHA
|
PL |
|
A
|
Aluminum Corporation of China Ltd
XMUN:AOC
|
CN |
Dividends
Dividend Yield
Ascendis Pharma A/S
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Ascendis Pharma A/S
A71 have decreased by 0%.
Payout Ratio
Ascendis Pharma A/S
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for A71 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
A71 Price
Ascendis Pharma A/S
| Average Annual Return | 1.46% |
| Standard Deviation of Annual Returns | 6.86% |
| Max Drawdown | -51% |
| Market Capitalization | 16.6B EUR |
| Shares Outstanding | 57 152 300 |
| Percentage of Shares Shorted |
N/A
|
